Unifying health data from 18+ wearables with intelligent AI insights • Pre-launch platform seeking seed funding
View Investment OpportunityHealthcare is broken and fragmented. Health data is everywhere, but insights are nowhere.
Existing solutions are single-device ecosystems (Apple Health, Fitbit). Norvana is the device-agnostic AI platform that unifies everything.
Unified Health Intelligence Platform
Connect 18+ wearables including Whoop, Oura, Garmin, Apple Watch, Eight Sleep, Fitbit, and more. Device-agnostic platform that works with everything you own.
Leading frontier AI models for medical reasoning, real-time health predictions, personalized recommendations, and Digital Twin simulations.
Activity & fitness, nutrition, sleep analysis, medications, medical records, DNA testing, and blood work—all in one platform.
On-demand doctor consultations, real-time medical transcription, AI clinical assistant, and FHIR R5 integration for EHR systems.
HIPAA & GDPR compliant, AES-256 encryption, multi-factor authentication, and comprehensive audit logging.
7 testing tiers from $125 to $1,500 with polygenic risk scores, pharmacogenomics, and personalized protocols.
Riding three converging megatrends: Wearables, AI, and Preventive Care
50M biohackers willing to pay $25-60/month for optimization
500M wearable owners seeking $5-20/month insights
1M doctors using telehealth at $125-600/month
100K employers at $5-15/employee/month
Diversified business model with strong unit economics
Target: 100K users = $23M ARR
Target: 10K users = $3.7M ARR
Target: 1K users = $1.5M ARR
Target: 1K doctors = $1.5M ARR
Target: 100 clinics = $7.5M ARR
Platform in active development • Launch subject to seed funding
Explore our comprehensive technical architecture, performance benchmarks, and infrastructure details
View Technology Platform →Target Market Opportunity
Small population ideal for national-scale pilot deployment. Post-funding, we aim to establish partnerships for clinical validation before broader European expansion.
Emerging Market Opportunity
Kenya & Tanzania offer opportunities to digitise healthcare delivery at scale. These markets have fewer regulatory constraints and high potential for impact with AI-powered solutions.
Latin America Expansion
Post-funding, we plan to establish pilot programmes with local clinics and doctors, integrating AI diagnostics and continuous health monitoring modules.
High-Value Regulatory Markets
Future expansion targets for establishing HIPAA/GDPR compliance credentials. These markets require significant regulatory investment post-funding.
Vision: National Health Operating System
Norvana's architecture is designed to operate as a national or regional health operating system, interoperable with existing health systems, and adaptable to diverse healthcare environments from emerging to mature markets.
Timeline subject to successful seed funding completion
Platform development in progress • Seeking $4M seed investment • Building core features • Market research and validation
Complete platform development • Launch marketing campaign • Begin pilot partner outreach • Target first beta users
Public launch in initial market • Corporate wellness pilots • Digital Twin v1 • Series A preparation
Market expansion • DNA testing integration • Healthcare provider partnerships • Mobile app v2.0
Scale operations • B2B2C corporate partnerships • Advanced longevity protocols • Revenue targets
Why Norvana will win this market
| Feature | Norvana | Apple Health | Whoop | Forward |
|---|---|---|---|---|
| Device Integrations | 18+ devices | iOS only | Single device | Limited |
| AI Insights | Advanced (Frontier AI) | Basic | Recovery only | Basic |
| Professional Care | Integrated | None | None | Physical locations |
| Price | $19.99/month | Free (locked) | $30/month | $149/month |
| Global Reach | Yes | Yes | Yes | US only |
Join us in revolutionizing preventive healthcare globally
| Metric | Year 1 (2026) | Year 2 (2027) | Year 3 (2028) |
|---|---|---|---|
| Total Revenue | $4M | $45M | $135M |
| Consumer Subscriptions | $2.5M | $28M | $82M |
| Healthcare Providers | $1.3M | $9M | $25M |
| Corporate Wellness | — | $6M | $19M |
| Lab Partnerships | $400K | $2M | $6.5M |
| Active Users | 20,000 | 150,000 | 500,000 |
| Gross Margin | 85% | 85% | 85% |
$96B → $639B digital health market with 37.8% CAGR
391 tests passing, enterprise security, scalable infrastructure
Device-agnostic platform unifying 18+ wearables with AI insights
12:1 LTV:CAC, 85% margins, 2.5-month payback
Proprietary models, Digital Twin, 99% accuracy
Wearable adoption + AI revolution + preventive care demand
4 government partnerships across Malta, Kenya, Tanzania, and pilot discussions in UK/US
Device-agnostic AI health OS integrating 18+ devices with unified interface
Target: $650M - $2B in 5-7 years (10-15x revenue multiple)
Subscribe Now at a Discount to the Upcoming Round
Get exclusive early access to our institutional round with preferential terms. US investors: SAFE (Simple Agreement for Future Equity) with 20% discount, US$2-10M tickets via Norvana LLC (Delaware).
Common questions about the investment opportunity
For US institutional investors, we're accepting investments of US$2-10M via SAFE (Simple Agreement for Future Equity) through Norvana LLC (Delaware). The SAFE includes a 20% discount to the next priced round with no valuation cap.
We're raising via YC-style SAFE with a 20% discount and no valuation cap through Norvana LLC (Delaware). US investors must be accredited under Rule 501(a) of Regulation D. The SAFE converts at 80% of the next priced round valuation. View full SAFE terms →
We're targeting a $650M - $2B exit in 5-7 years, representing a 10-15x revenue multiple. Our financial projections show $135M revenue by Year 3, with comparable exits including Livongo ($18.5B to Teladoc), Fitbit ($2.1B to Google), and One Medical ($3.9B to Amazon).
Norvana is device-agnostic (works with 18+ devices), while competitors lock users into single ecosystems. We offer advanced AI insights using frontier AI models, integrated professional care, and are building government partnerships for national health systems - none of our competitors have this combination.
We're already HIPAA and GDPR compliant with FHIR R5 integration. For the UK, we're pursuing UK MDR registration (Class I medical device). Our government partnerships in Malta, Kenya, Tanzania, and Mexico provide regulatory pathways in those markets. We're working with regulatory consultants in the US and EU for broader market access.
Key risks include: (1) Regulatory approval delays in major markets, (2) Competition from tech giants (Apple, Google), (3) Customer acquisition costs in consumer health, (4) Data security breaches. We're mitigating these through government partnerships (de-risks regulation), differentiated product (device-agnostic + AI), freemium model (lowers CAC), and enterprise-grade security (HIPAA/GDPR compliant).
40% Product Development ($1.5M): Enhanced AI, Digital Twin, additional integrations. 35% Go-to-Market ($1.3M): UK launch, Malta trial, East Africa deployment. 15% Team Expansion ($550K): AI engineers, healthcare professionals, sales. 10% Operations ($400K): Infrastructure, compliance, administration.
100% production-ready platform with 391 passing tests. 18+ wearable device integrations. 4 government partnerships: Malta Ministry of Health (national trial), Kenya & Tanzania (deployment agreements), Mexico (clinical pilots). $4M projected Year 1 revenue. Zero technical debt.
Our projections show positive EBITDA in Year 3 (2028) with 85% gross margins throughout. Strong unit economics (12:1 LTV:CAC, 2.5-month payback) enable rapid scaling. Government contracts provide immediate revenue, while consumer subscriptions scale profitability.
Absolutely! We're based in the UK and happy to arrange in-person meetings or virtual demos. You can book a demo call directly through our calendar, try our platform at beta.norvana.ai, or contact us to schedule an office visit. We're also attending key health tech conferences in 2026.
Our team is ready to answer any questions you have about the investment opportunity
Help millions optimize their health and prevent disease. Together, we can make preventive healthcare accessible to everyone.